Login / Signup

Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma.

Yuqing PeiXiaoying LouKexin LiXiaotian XuYe GuoDanfei XuZhenxi YangDongsheng XuWei CuiDonghong Zhang
Published in: OncoTargets and therapy (2020)
Leukocyte m6A represents a potential noninvasive biomarker for NSCLC screening, monitoring and diagnosis.
Keyphrases
  • peripheral blood
  • small cell lung cancer
  • single cell
  • cell therapy
  • advanced non small cell lung cancer
  • stem cells
  • human health
  • mesenchymal stem cells
  • risk assessment
  • climate change